Bioharvest Sciences Inc (BHST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,602 | -752 | -11,236 | -8,430 | -4,506 |
| Depreciation Amortization | 407 | 198 | 712 | 520 | 326 |
| Accounts receivable | 122 | 153 | -588 | -222 | -183 |
| Other Working Capital | 316 | 604 | -308 | 38 | 12 |
| Other Operating Activity | -1,776 | -1,858 | 2,179 | 1,357 | 112 |
| Operating Cash Flow | $-4,533 | $-1,655 | $-9,241 | $-6,737 | $-4,239 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -743 | -376 | -1,256 | -993 | -714 |
| Investing Cash Flow | $-743 | $-376 | $-1,256 | $-993 | $-714 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,140 | 700 | 7,658 | 5,307 | 2,118 |
| Common Stock Issued | 403 | N/A | 877 | 876 | 146 |
| Other Financing Activity | -179 | -83 | -397 | -276 | -192 |
| Financing Cash Flow | $5,364 | $617 | $8,138 | $5,907 | $2,072 |
| Exchange Rate Effect | -12 | -22 | -22 | -22 | -22 |
| Beginning Cash Position | 1,736 | 1,736 | 4,117 | 4,117 | 4,117 |
| End Cash Position | 1,812 | 300 | 1,736 | 2,272 | 1,214 |
| Net Cash Flow | $88 | $-1,436 | $-2,359 | $-1,845 | $-2,903 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,533 | -1,655 | -9,241 | -6,737 | -4,239 |
| Capital Expenditure | -743 | -376 | -1,256 | -993 | -714 |
| Free Cash Flow | -5,276 | -2,031 | -10,497 | -7,730 | -4,953 |